A comparison of the efficacy and tolerability of the PCSK9 inhibitors, Alirocumab and evolocumab, in routine lipid clinic practice. (August 2017)

Record Type:: Journal Article
Title:: A comparison of the efficacy and tolerability of the PCSK9 inhibitors, Alirocumab and evolocumab, in routine lipid clinic practice. (August 2017)
Main Title:: A comparison of the efficacy and tolerability of the PCSK9 inhibitors, Alirocumab and evolocumab, in routine lipid clinic practice
Authors:: Jones, Alan
Peers, Kate
Ramachandran, Sud
Syed, Ateeq
Abstract:
Is Part Of:: Atherosclerosis. Volume 263(2017)
Journal:: Atherosclerosis
Issue:: Volume 263(2017)
Issue Display:: Volume 263, Issue 2017 (2017)
Year:: 2017
Volume:: 263
Issue:: 2017
Issue Sort Value:: 2017-0263-2017-0000
Page Start:: e247
Page End:
Publication Date:: 2017-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2017.06.802 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4422.xml